EICHORPublic-registry site landscape for NCT04444427, “Evaluation of GLR2007 for Advanced Solid Tumors”, a Non-small Cell Lung Cancer study sponsored by Gan and Lee Pharmaceuticals, USA. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04444427 (registry record) |
| Study title | Evaluation of GLR2007 for Advanced Solid Tumors |
| Official title | An Open-Label, Multicenter, Phase 1b/2 Study to Establish Safety, Tolerability, and Optimal Dosing Strategy of GLR2007 in Subjects With Advanced Solid Tumors |
| Sponsor | Gan and Lee Pharmaceuticals, USA |
| Condition(s) | Non-small Cell Lung Cancer; Glioblastoma Multiforme |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 4 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT04444427.
Eichor generates a preliminary site-risk snapshot for NCT04444427 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Non-small Cell Lung Cancer trials
← Eichor home · All tracked trials · Non-small Cell Lung Cancer studies · Weekly briefs
